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The importance of the integrations of treat-
ment expectations in patient care has received 
considerable attention in recent years, with a 
proliferation of newly developed instruments 
in the past decades [1]. This is a reflection, 
perhaps, of an acknowledgement that what 
patients hope for, expect or anticipate, which 
is an important predictor of treatment out-
comes [2], exemplified, for example, by what 
significance patients put on medication [3].
Patients’ expectations of illness, health-
care satisfaction and treatment [2,4] have 
been defined in a number of ways, for exam-
ple, ‘the anticipation that given events are 
likely to occur during, or as an outcome of 
healthcare’ [2]. However, disagreement pre-
vails, including in the measurement of its 
components.
The treatment of rheumatoid arthritis 
(RA), an inflammatory autoimmune dis-
ease, has radically changed over the last 
decades with the key aim from the clini-
cians’ perspective to achieve rapid and sus-
tained remission as measured by the Dis-
ease Activity Score [5]. In contrast, patients’ 
individual goals tend to focus on reduced 
pain and fatigue, improved mobility, con-
tinuation of employment and help with 
psychological impacts, such as depression 
or anxiety [6]. The patients’ goals may be 
achieved as a result of suppression of the 
Disease Activity Score, however, this is 
not uniform. Pain and fatigue often persist 
despite improved disease activity [7]. This 
observation serves to highlight that patients 
need holistic care that extends beyond sim-
ply immunosuppression. Patient-centered 
care delivered by multidisciplinary teams, 
incorporating education, psychological sup-
port, self-management advice, life style and 
exercise guidance are all recommended [8]. 
However, lack of resources means that such 
comprehensive care is infrequently available 
within the National Health Service of the 
UK. Data from the National Early Arthri-
tis Audit due to be published in the autumn 
of 2015 will shed more light on this lack of 
optimal services for patients with RA. Typi-
cally, treatment consists mostly of disease-
modifying antirheumatic drug (DMARD) 
monotherapy, combinations of DMARDs 
(with or without glucocorticoids) and 
DMARD–biologics combination follow-
ing the ‘treatment to target’ approach with 
education and self-management support, 
provided ad hoc by the clinical care team [9]. 
One can argue that the mantra of ‘treat to 
target’ has too narrow a focus and does not 
truly align with patient-centered care.
An appreciation of how patients’ expecta-
tions relates to RA care is important. Con-
sider, for example, how clinicians might 
communicate the effectiveness of therapy. A 
practitioner may allude to a high probability 
to achieve remission when a patient is com-
menced on a biologic. If this information 
influences the patient’s expectations, it may 
in turn sway concordance and thus lead to 
an improvement of success. In other fields 
of medicine, it has been observed that when 
clinicians set patients’ expectations high, 
medication becomes more effective [10].
Patients’ expectations in relation to treat-
ment are based on knowledge and previous 
experiences within the healthcare environ-
ment [11]. The assessment of the probability 
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of risk and benefit [4] is a subjective process that is sub-
stantially influenced by pre-existing health beliefs [2]. 
A number of theoretical models have been suggested 
to underpin patients’ treatment expectations, most 
of which are based on the Social Learning Theory 
by Bandura [12] that considers why people behave the 
way they do within the context of their social envi-
ronment. Expectations and beliefs that patients hold 
about their illness and treatment are conceptualized 
in the Common Sense Model of Illness [13] and the 
Necessity-Concerns Framework [14], respectively and 
have been shown to be related to a number of self-
management behaviors and illness outcomes in a range 
of long-term conditions, including RA [15]. Typically, 
those who expect their illness to last a long time (even 
when symptoms are not currently present), report sig-
nificant consequences to their lives (such as disability) 
and have confidence that their treatment is effective, 
tend to exhibit better treatment adherence, quality of 
life and disease control [16].
Crow et al. [17] go further and identified the three 
outcome expectations that are either treatment or 
patient related: beliefs that certain actions will achieve 
particular outcomes (e.g., taking the medication will 
reduce pain and stiffness; regular blood monitor-
ing will minimize side-effects of treatment); process 
expectations: beliefs about the content and process of 
interventions (e.g., side effects of medication/detailed 
information and ongoing support by healthcare profes-
sionals); and self-efficacy expectations: beliefs in ones 
capabilities to organize and execute a certain course 
of action to achieve the required goal (e.g., exercising 
to keep mobile and reduce stiffness, pacing). The first 
two outcome expectations above are treatment related, 
while the latter is patient-related. This distinction may 
be helpful in consultations with patients and in the 
development or applications of treatment expectation 
scales [1,3].
Being able to measure or elicit patients’ expecta-
tions is an important first step in managing outcomes. 
A systematic review of treatment and patient-related 
expectations in musculoskeletal disorders [1] included 
24 scales across a range of musculoskeletal conditions, 
for example, self-efficacy scales for back pain, athletic 
injury, childhood arthritis, RA, knee surgery, etc.; but 
these lacked data on validity and reliability. Due to the 
wide range of diseases, it was difficult to compare the 
scales. The common sense model tells us that patients’ 
expectations are likely to change over time as they 
assimilate new knowledge and experience of their ill-
ness. Therefore, multiple measurements are needed to 
assess the effect of an intervention that focuses on man-
aging expectations. This is currently underway with a 
treatment expectation scale for new treatment [3] in a 
national longitudinal observational study of patients 
with early RA with 18 months follow-up, due to be 
completed this year.
Understanding the nature, formulation and expres-
sion of patients’ expectations is essential to management 
and subsequently, satisfaction with the healthcare, pro-
fessional–patient relationship and self-management of 
the illness. Patients are invited to be involved in mak-
ing decisions about their healthcare that is informed 
by best practice and tailored to individual patient 
characteristics. Towle and Godolphin [18] describe 
a framework for both healthcare professionals and 
patients to facilitate shared decision-making, which 
includes elucidating and offering beliefs, concerns and 
expectations of treatment. Charles et al.’s model [19] 
takes this further and suggests that both parties take 
steps to build a consensus about preferred treatments 
and that an agreement is reached on the treatment 
to implement. Although in some cases this approach 
would be inappropriate, for long-term management of 
RA, which relies heavily on patient self-management, 
outcomes are improved when patients are actively 
involved in treatment decisions [20]. Managing and 
aligning expectations can be seen as problematic in RA 
due to frequent prescription changes and escalations 
needed to ‘treat to target’. Inaccurate expectations 
can be modified through education and motivational 
interviewing [15,16] to promote shared decision-making.
In summary, patients’ expectations are infrequently 
taught as a clinical concept, yet it is now increasingly 
understood to be central to medical practice. The rec-
ognition that perceived outcomes of care differ greatly 
between individuals and learning how clinicians can 
capture and utilize such information, is a worthy goal 
for future research. Good decision-making requires 
both doctors/nurses and patient to be familiar with the 
evidence-based facts and to be able to weigh up the 
pros and cons of the alternatives. Inextricably linked 
to this is the understanding of the difference between 
awareness of medical information and the importance 
of patients’ value-based j udgement.
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